Top Clicks This Month

Not Intended for Therapeutic Use. For research use only.

Epothilone D - CAS 189453-10-9

Quick Inquiry

Name:
* Email:
* Service & Products of Interest:
* Quantity:
* Verification code:
Please input "bocsci" as verification code.
Category
Inhibitor
Product Name
Epothilone D
Catalog Number
189453-10-9
Synonyms
Oxacyclohexadec-13-ene-2,6-dione, 4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl-, (4S,7R,8S,9S,13Z,16S)-; Oxacyclohexadec-13-ene-2,6-dione, 4,8-dihydroxy-5,5,7,9,13-pentamethyl -16-(1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)-,(4S-(4R*,7S,8R*,9R*,1 3Z,16R*(E)))-; (3S,7S,14S,15S,16R)-3,15-Dihydroxy-2,2,10,14,16-pentamethyl-7-[1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-6-oxacyclohexadec-9-ene-1,5-dione; Epothilone D; Desoxyepothilone B; (4S,7R,8S,9S,13Z,16S)-4,8-Dihydroxy-5,5,7,9,13-pentaMethyl-16-[(1E)-1-Methyl-2-(2-Methyl-4-thiazolyl)ethenyl]oxacyclohexadec-13-ene-2,6-dione; 12,13-Desoxyepothilone B; Epo D
CAS Number
189453-10-9
Description
Epothilone D is a natural polyketide compound isolated from the myxobacterium Sorangium cellulosum. Also known as desoxyepothilone B, epothilone D binds to tubulin and inhibits the disassembly of microtubules, resulting in the inhibition of mitosis, cellular proliferation, and cell motility.
Molecular Weight
491.68
Molecular Formula
C27H41NO5S
Quantity
Grams-Kilos
Quality Standard
In-house Standard
COA
Certificate of Analysis-Epothilone D 189453-10-9 B15JA0722  
MSDS
Inquire
Canonical SMILES
CC1CCCC(=CCC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC2=CSC(=N2)C)C)C
InChI
1S/C27H41NO5S/c1-16-9-8-10-17(2)25(31)19(4)26(32)27(6,7)23(29)14-24(30)33-22(12-11-16)18(3)13-21-15-34-20(5)28-21/h11,13,15,17,19,22-23,25,29,31H,8-10,12,14H2,1-7H3/b16-11-,18-13+/t17-,19-,22-,23-,25-/m0/s1
InChIKey
XOZIUKBZLSUILX-XWIMUJDOSA-N
Targets
Microtubule/Tubulin
Current Developer
Kosan.
Size Price Stock Quantity
10 mg $190 In stock
50 mg $890 In stock

Bulk Inquiry

Name:
* Email:
* Service & Products of Interest:
* Quantity:
* Verification code:
Please input "bocsci" as verification code.
Structure
CAS 189453-10-9 Epothilone D
Specification
Purity
≥ 98.0%
Boiling Point
663.658 °C at 760 mmHg
Melting Point
63-66ºC
Density
1.085 g/cm3
Appearance
White solid
Application
Anti-neoplastic
Storage
Store at -20ºC Freezer
Solubility
Chloroform (Slightly), DMSO (Slightly)
Related Microtubule/Tubulin Products
  • CAS 162652-95-1 Vinflunine

    Vinflunine
    (CAS: 162652-95-1)

    Vinflunine is a new vinca alkaloid uniquely fluorinated with the properties of mitotic-arresting and tubulin-interacting activity.

  • PBOX-15
    (CAS: 354759-10-7)

    PBOX-15 is a novel microtubule inhibitor, which induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cel...

  • CAS 141430-65-1 ABT 751

    ABT 751
    (CAS: 141430-65-1)

    ABT 751, also called E7010, is a a novel bioavailable tubulin-binding and antimitotic agent (in neuroblastoma: IC50= 0.6–2.6 μM; in non-neuroblastoma cell line...

  • CAS 168555-66-6 Fosbretabulin disodium

    Fosbretabulin disodium
    (CAS: 168555-66-6)

    Fosbretabulin disodium is the disodium salt of a water-soluble phosphate derivative of a natural stilbenoid phenol derived from the African bush willow (Combret...

  • CAS 865-21-4 Vinblastine

    Vinblastine
    (CAS: 865-21-4)

    Vinblastine is inhibitor of nAChR and can inhibit the formation of microtubule. It is a natural alkaloid isolated from the plant Vinca rosea Linn. It binds to t...

  • CAS 917369-31-4 MPC 6827 hydrochloride

    MPC 6827 hydrochloride
    (CAS: 917369-31-4)

    MPC 6827 hydrochloride, the hydrochloride salt form of verubulin, inhibits of microtubule formation (IC50 = 1.5 - 3.4 nM). in vitro: inhibits polymerization of...

  • CAS 194468-36-5 Vinflunine ditartrate

    Vinflunine ditartrate
    (CAS: 194468-36-5)

    Vinflunine, a semisynthetic derivative of Vinorelbine, is the first fluorinated microtubule inhibitor belonging to the Vinca alkaloids family endowed with uniqu...

  • CAS 183133-96-2 Cabazitaxel

    Cabazitaxel
    (CAS: 183133-96-2)

    Cabazitaxel increases CYP3A enzyme activities in rat hepatocytes. The mean ex-vivo human plasma protein binding of Cabazitaxel is 91.6%.

  • CAS 143-67-9 Vinblastine sulfate

    Vinblastine sulfate
    (CAS: 143-67-9)

    Vinblastine sulfate, also called cellblastin, derived from C. roseus, as a microtubule disrupter and antineoplastic agent, it binds tubulin and disrupts microtu...

  • CAS 204205-90-3 Indibulin

    Indibulin
    (CAS: 204205-90-3)

    Indibulin, also called D 24851, estabilizes tubulin polymerization (IC50 = 0.3 μM) and induces tumor cell cycle arrest and apoptosis. In vitro: blocking cell cy...

  • CKD-516 HCl
    (CAS: 1188371-47-2)

    This active molecular is a tubulin polymerisation inhibitor which is applicated for solid cancer treatment. CKD-516 disruptes tubulin of the endothelial cytoske...

  • INDY
    (CAS: 1169755-45-6)

    INDY,under the IUPAC name 1-(3-ethyl-5-hydroxy-1,3-benzothiazol-2-ylidene)propan-2-one, is a DYRK1A/B inhibitor (DYRK1B: IC50= 0.23μM; DYRKA: IC50= 0.230.24μM)....

  • CAS 90332-66-4 7-xylosyltaxol

    7-xylosyltaxol
    (CAS: 90332-66-4)

    7-xylosyltaxol is a taxol (Paclitaxel) derivative, which binds to tubulin and inhibits the disassembly of microtubules.

  • CAS 945771-74-4 BNC-105

    BNC-105
    (CAS: 945771-74-4)

    BNC105 is a novel compound being developed by Bionomics as a Vascular Disrupting Agent (VDA) for treatment of cancer. VDAs are drugs that disrupt the blood vess...

  • DM1-SMCC
    (CAS: 1228105-51-8)

    This active molecular is DM1 with a linker SMCC that can react with antibody to make antibody drug conjugate. DM1 is an antibody-conjugatable maytansinoid that ...

  • CAS 33069-62-4 Taxol

    Taxol
    (CAS: 33069-62-4)

    Taxol, also called Paclitaxel, derived from the bark of the Pacific yew tree, has a broad antineoplastic spectrum uused in cancer chemotherapy.It promotes and s...

  • CAS 152044-54-7 Epothilone B

    Epothilone B
    (CAS: 152044-54-7)

    Epothilone B, also called Patupilone, is a microtubule stabilization agent (EC0.01= 1.8 μM). It induces mitotic arrest at the G2-M transition in Hs578T (IC50 = ...

  • Flutax 1
    (CAS: 191930-58-2)

    Flutax 1, the more soluble difluoro-fluorescein derivative with improved photostability Flutax-2, binds to the taxol microtubule binding site with high affinity...

  • CAS 917111-44-5 Lexibulin

    Lexibulin
    (CAS: 917111-44-5)

    lexibulin, also known as CYT997,  is an orally bioavailable small-molecule with tubulin-inhibiting, vascular-disrupting, and potential antineoplastic activ...

  • CAS 1201898-17-0 Vinflunine Tartrate

    Vinflunine Tartrate
    (CAS: 1201898-17-0)

    Vinflunine induces apoptosis in neuroblastoma SK-N-SH cells through a postmitotic G1 arrest and a mitochondrial pathway in a concentration-dependent manner with...

Reference Reading
1.Nanomolar concentrations of epothilone D inhibit the proliferation of glioma cells and severely affect their tubulin cytoskeleton
Dietzmann, D. Kanakis, E. Kirches, S. Kropf, C. Mawrin and K. Dietzmann. Journal of Neuro-Oncology 65: 99–106, 2003
Since a long time, colchizine, podophyllotoxins and vinblastin are known to cause cell death by destabilizing microtubules. However, not only agents promoting microtubule degradation might be used as antiproliferative and cytotoxic drugs, but also microtubule stabilizing agents. Microtubules are small hollow cylinders composed of 13 parallel rows of globular proteins, α- and β-tubulin. These cylinders can grow on one edge and melt down at the other by non-enzymatic addition or removal of tubulin heterodimers. The balance between polymerization and depolymerization depends on the accessible concentration of free, soluble tubulin, but is modulated by some accessory proteins and strongly influenced by certain drugs, which can bind to specific sites of the β-tubulin molecule. The drug taxol, which was discovered in the early 80s, was the first example of such a compound, which binds β-tubulin and thereby inhibits tubulin depolymerization. In the presence of taxol, microtubule turnover is disturbed by this stabilizing effect.
2.Synthesis of Epothilone D with the Forced Application of Oxycyclopropane Intermediates
L. Hurski and O. G. Kulinkovich. Russian Journal of Organic Chemistry, 2011, Vol. 47, No. 11, pp. 1653−1674.
The yields of epothilone D (I) in the synthesis we developed in the longest linear successions of 23 stages proceeding from diethyl adipate and 24 stages, from (R)-methyl 2,3-О-isopropylidene glycerate (XX) were 2 and 1.6% respectively. It is close to the average number of stages and overall yield (2.3%) in the previously described approaches. The overall number of stages of the synthesis of epothilone D (I) carried out in this study was as expected considerably larger than the average number in the known syntheses. Yet as the advantages of the used approach should be mentioned the experimental simplicity of performing the reactions of cyclopropanols preparation and the reactions of the cleavage of the three-membered ring of hydroxycyclopropane intermediates, and also the low price of the corresponding reagents and catalysts. The latter statement was quantitatively illustrated by the estimation from the catalog data the average price of the molar amounts of reagents and the corresponding proportional quantities of catalysts. In the previously published syntheses of epothilone D it equaled 37 × 103 € ·mol–1, whereas in this work it was 11×103 € ·mol–1. The latter value had the smallest absolute magnitude, and calculated per 1% of epothilone D (I) yield this approach was in the first five “profitable” procedures.
3.Building Blocks for (C15–C3)-Modified Epothilone D Analogs
R. F. Valeev, R. F. Bikzhanov, and M. S. Miftakhov. Russian Journal of Organic Chemistry, 2014, Vol. 50, No. 10, pp. 1511–1519
We previously planned to synthesize new metabolically and chemically more stable epothilone D (I) analogs, compounds II and III with isosterically displaced methylene unit in the C15–C3 fragment. We presumed that, unlike readily hydrolyzable in vivo macrolide I, its analogs II and III contain more stable lactam and lactone fragments, respectively (the C1=O carbonyl group is sterically hindered and is stabilized by the C1=O···HO–C2 hydrogen bond, and elimination of the C2-hydroxy group is impossible). Such isosteric rearrangement of the C15–C3 fragment of natural epothilone I has not been reported. This structural modification should affect the stability of the resulting compounds and change their conformation upon binding to tubulin, so that their biological activity should change. The above considerations determined the choice of compounds II and III as target structures. Compound III is an isostere of epothilone D (I), which is important from the viewpoint of estimation of the effect of modification of the C15–C3 fragment on the biological activity of epothilones.
4.Alternative Synthesis of Thiazole-Substituted Fragment С10–С21 of Epothilone D Analog
R. F. Valeev, R. F. Bikzhanov, and M. S. Miftakhov. Russian Journal of Organic Chemistry, 2015, Vol. 51, No. 5, pp. 660–663.
Epothilones, especially their analogs, are very promising objects for designing and synthesis of anticancer compounds of tubulin-polymerizing (taxol-like) action. In our planned synthetic approach to analogs of epothilone D 1a and 1b a block 2 with thiazole substituent is one of the key synthons.
2005 - BOC Sciences | All rights reserved
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE